Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.

Similar Publications

• Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.

  S Vincent Rajkumar, Susanna Jacobus, Natalie S Callander, Rafael Fonseca, David H Vesole, Michael E Williams, Rafat Abonour, David S Siegel, Michael Katz, Philip R Greipp

• Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.

  Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, Angela Dispenzieri, Francis Buadi, Shaji Kumar, Philip R Greipp, John A Lust, Stephen J Russell, David Dingli, Robert A Kyle, Rafael Fonseca, P Leif Bergsagel, Vivek Roy, Joseph R Mikhael, A Keith Stewart, Kristina Laumann, Jacob B Allred, Sumithra J Mandrekar, S Vincent Rajkumar

• Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma.

  Hirokazu Murakami, Hiroshi Handa, Masahiro Abe, Sinsuke Iida, Akihiro Ishii, Takayuki Ishikawa, Tadao Ishida, Masatsugu Oota, Shuji Ozaki, Masaaki Kosaka, [......], Morio Sawamura, Chihiro Shimazaki, Kazuyuki Shimizu, Toshiyuki Takagi, Hiroyuki Hata, Takashi Fukuhara, Hiroshi Fujii, Akira Miyata, Toshio Wakayama, Kiyoshi Takatsuki